Birdwatch Note
2024-09-27 08:46:31 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La thèse porte sur les intoxications aiguës (suicides) avec la chloroquine (Nivaquine®) et non l’hydroxychloroquine (Plaquenil®). Le risque de l’hydroxychloroquine est favorisé par l’hypokaliémie et l’atteinte cardiaque des patients COVID-19 . https://sfpt-fr.org/covid19-foire-aux-questions/1094-la-chloroquine-ou-l-hydroxychloroquine-sont-elles-efficaces-pour-prevenir-ou-traiter-l-infection-par-coronavirus
Written by 3808C1C8861A3AC9CC4708577DB64D6B06ECFD5E363CB00308558C53EE83C906
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1839033052380672390
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1839587413162606727
- noteId - 1839587413162606727
- participantId -
- noteAuthorParticipantId - 3808C1C8861A3AC9CC4708577DB64D6B06ECFD5E363CB00308558C53EE83C906 Participant Details
- createdAtMillis - 1727426791837
- tweetId - 1839033052380672390
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La thèse porte sur les intoxications aiguës (suicides) avec la chloroquine (Nivaquine®) et non l’hydroxychloroquine (Plaquenil®). Le risque de l’hydroxychloroquine est favorisé par l’hypokaliémie et l’atteinte cardiaque des patients COVID-19 . https://sfpt-fr.org/covid19-foire-aux-questions/1094-la-chloroquine-ou-l-hydroxychloroquine-sont-elles-efficaces-pour-prevenir-ou-traiter-l-infection-par-coronavirus
Note Ratings
| rated at | rated by | |
| 2024-09-30 15:03:36 -0500 | Rating Details | |
| 2024-09-30 00:51:19 -0500 | Rating Details | |
| 2024-09-29 17:01:32 -0500 | Rating Details | |
| 2024-09-29 16:29:16 -0500 | Rating Details | |
| 2024-09-29 15:36:54 -0500 | Rating Details | |
| 2024-09-29 13:11:36 -0500 | Rating Details | |
| 2024-09-29 10:56:17 -0500 | Rating Details | |
| 2024-09-29 08:36:06 -0500 | Rating Details | |
| 2024-09-29 08:24:47 -0500 | Rating Details | |
| 2024-09-29 06:01:34 -0500 | Rating Details | |
| 2024-09-29 05:36:27 -0500 | Rating Details | |
| 2024-09-29 03:30:09 -0500 | Rating Details | |
| 2024-09-29 03:30:00 -0500 | Rating Details | |
| 2024-09-29 03:23:21 -0500 | Rating Details | |
| 2024-09-29 03:05:42 -0500 | Rating Details | |
| 2024-09-29 02:51:00 -0500 | Rating Details | |
| 2024-09-29 02:45:36 -0500 | Rating Details | |
| 2024-09-29 02:34:55 -0500 | Rating Details | |
| 2024-09-29 02:19:12 -0500 | Rating Details | |
| 2024-09-29 01:46:03 -0500 | Rating Details | |
| 2024-09-29 01:41:10 -0500 | Rating Details | |
| 2024-09-29 01:27:18 -0500 | Rating Details | |
| 2024-09-29 01:19:41 -0500 | Rating Details | |
| 2024-09-29 01:08:47 -0500 | Rating Details | |
| 2024-09-29 00:46:05 -0500 | Rating Details | |
| 2024-09-29 00:39:40 -0500 | Rating Details | |
| 2024-09-29 00:36:07 -0500 | Rating Details | |
| 2024-09-29 00:28:31 -0500 | Rating Details | |
| 2024-09-29 00:15:27 -0500 | Rating Details | |
| 2024-09-29 00:13:26 -0500 | Rating Details | |
| 2024-09-29 00:05:09 -0500 | Rating Details | |
| 2024-09-29 00:01:34 -0500 | Rating Details | |
| 2024-09-28 18:54:45 -0500 | Rating Details | |
| 2024-09-28 05:27:10 -0500 | Rating Details | |
| 2024-09-28 02:05:21 -0500 | Rating Details | |
| 2024-09-27 22:37:39 -0500 | Rating Details | |
| 2024-09-27 17:55:29 -0500 | Rating Details | |
| 2024-09-27 17:22:55 -0500 | Rating Details | |
| 2024-09-27 16:19:41 -0500 | Rating Details | |
| 2024-09-27 15:48:13 -0500 | Rating Details | |
| 2024-09-27 14:35:20 -0500 | Rating Details | |
| 2024-09-27 14:09:26 -0500 | Rating Details | |
| 2024-09-27 13:35:44 -0500 | Rating Details | |
| 2024-09-27 13:08:53 -0500 | Rating Details | |
| 2024-09-27 12:45:45 -0500 | Rating Details | |
| 2024-09-27 12:30:55 -0500 | Rating Details | |
| 2024-09-27 12:26:19 -0500 | Rating Details | |
| 2024-09-27 11:24:18 -0500 | Rating Details | |
| 2024-09-27 10:48:31 -0500 | Rating Details | |
| 2024-09-27 10:09:25 -0500 | Rating Details | |
| 2024-09-27 10:05:43 -0500 | Rating Details | |
| 2024-09-27 09:59:09 -0500 | Rating Details | |
| 2024-09-27 09:47:27 -0500 | Rating Details | |
| 2024-09-27 09:46:25 -0500 | Rating Details | |
| 2024-09-27 09:02:21 -0500 | Rating Details | |
| 2024-09-27 08:56:04 -0500 | Rating Details | |
| 2024-09-27 08:44:12 -0500 | Rating Details | |
| 2024-09-27 08:35:30 -0500 | Rating Details | |
| 2024-09-27 08:30:44 -0500 | Rating Details | |
| 2024-09-27 08:15:45 -0500 | Rating Details | |
| 2024-09-27 08:13:31 -0500 | Rating Details | |
| 2024-09-27 07:48:19 -0500 | Rating Details | |
| 2024-09-27 07:47:06 -0500 | Rating Details | |
| 2024-09-27 07:43:38 -0500 | Rating Details | |
| 2024-09-27 07:28:14 -0500 | Rating Details | |
| 2024-09-27 07:12:49 -0500 | Rating Details | |
| 2024-09-27 07:09:12 -0500 | Rating Details | |
| 2024-09-27 06:59:14 -0500 | Rating Details | |
| 2024-09-27 06:31:53 -0500 | Rating Details | |
| 2024-09-27 06:31:37 -0500 | Rating Details | |
| 2024-09-27 06:18:49 -0500 | Rating Details | |
| 2024-09-27 06:15:12 -0500 | Rating Details | |
| 2024-09-27 06:13:16 -0500 | Rating Details | |
| 2024-09-27 05:54:09 -0500 | Rating Details | |
| 2024-09-27 05:42:06 -0500 | Rating Details | |
| 2024-09-27 05:36:13 -0500 | Rating Details | |
| 2024-09-27 05:25:26 -0500 | Rating Details | |
| 2024-09-27 05:23:08 -0500 | Rating Details | |
| 2024-09-27 05:15:15 -0500 | Rating Details | |
| 2024-09-27 05:08:48 -0500 | Rating Details | |
| 2024-09-27 05:08:46 -0500 | Rating Details | |
| 2024-09-27 05:07:40 -0500 | Rating Details | |
| 2024-09-27 04:53:05 -0500 | Rating Details | |
| 2024-09-27 04:52:12 -0500 | Rating Details | |
| 2024-09-27 04:48:21 -0500 | Rating Details | |
| 2024-09-27 04:44:02 -0500 | Rating Details | |
| 2024-09-27 04:38:54 -0500 | Rating Details | |
| 2024-09-27 04:33:10 -0500 | Rating Details | |
| 2024-09-27 04:10:55 -0500 | Rating Details | |
| 2024-09-27 04:04:06 -0500 | Rating Details | |
| 2024-10-01 12:54:30 -0500 | Rating Details | |
| 2024-10-01 01:46:09 -0500 | Rating Details | |
| 2024-09-28 01:47:45 -0500 | Rating Details | |
| 2024-10-01 02:08:01 -0500 | Rating Details | |
| 2024-09-29 09:22:21 -0500 | Rating Details | |
| 2024-09-29 03:03:07 -0500 | Rating Details | |
| 2024-09-29 02:01:58 -0500 | Rating Details | |
| 2024-09-29 01:39:41 -0500 | Rating Details | |
| 2024-09-29 01:23:10 -0500 | Rating Details | |
| 2024-09-29 01:03:36 -0500 | Rating Details | |
| 2024-09-29 00:06:29 -0500 | Rating Details | |
| 2024-09-28 09:02:36 -0500 | Rating Details | |
| 2024-09-27 16:45:21 -0500 | Rating Details | |
| 2024-09-27 11:31:29 -0500 | Rating Details | |
| 2024-09-27 09:20:49 -0500 | Rating Details | |
| 2024-09-27 05:03:08 -0500 | Rating Details | |
| 2024-09-27 04:25:56 -0500 | Rating Details | |
| 2024-10-28 09:45:09 -0500 | Rating Details | |
| 2024-10-10 12:58:12 -0500 | Rating Details | |
| 2024-11-13 00:21:20 -0600 | Rating Details |